Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:FREQ

Frequency Therapeutics (FREQ) Stock Price, News & Analysis

Frequency Therapeutics logo

About Frequency Therapeutics Stock (NASDAQ:FREQ)

Advanced Chart

Key Stats

Today's Range
$0.28
$0.32
50-Day Range
$0.22
$14.98
52-Week Range
$0.18
$16.00
Volume
309,164 shs
Average Volume
822,537 shs
Market Capitalization
$10.94 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive FREQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Frequency Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

FREQ Stock News Headlines

Transform with 528Hz Frequency 🔊
Presidential Bombshell: $150T Resource to Be Released as soon as this Summer?
Something extraordinary is happening in Washington. For the first time in over a century, a sitting President could release a national treasure that's been tied up in red tape, for generations. I'm talking about a $150 trillion American asset that's scattered across all 50 states. While the mainstream media focuses on political theater, this story is quietly developing behind closed doors.
Trevi Therapeutics RIVER trial meets primary endpoint
Trevi Therapeutics RIVER trial meets primary endpoint
Silence Therapeutics Advances Promising siRNA Therapy for PV
See More Headlines

FREQ Stock Analysis - Frequently Asked Questions

Frequency Therapeutics, Inc. (NASDAQ:FREQ) issued its earnings results on Monday, November, 15th. The company reported ($0.73) EPS for the quarter, missing the consensus estimate of ($0.57) by $0.16.

Frequency Therapeutics (FREQ) raised $102 million in an initial public offering on Thursday, October 3rd 2019. The company issued 6,700,000 shares at $14.50-$16.00 per share. J.P. Morgan, Goldman Sachs and Cowen acted as the underwriters for the IPO and Mizuho Securities was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Frequency Therapeutics investors own include Tesla (TSLA), ImmunoGen (IMGN), Advanced Micro Devices (AMD), AMC Entertainment (AMC), Ovintiv (OVV), Plug Power (PLUG) and TherapeuticsMD (TXMD).

Company Calendar

Last Earnings
11/15/2021
Today
7/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:FREQ
CIK
1703647
Fax
N/A
Employees
46
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.89)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$81.58 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-107.67%
Return on Assets
-61.40%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
5.81
Quick Ratio
5.81

Sales & Book Value

Annual Sales
$14.07 million
Price / Sales
0.78
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.96 per share
Price / Book
0.15

Miscellaneous

Outstanding Shares
36,520,000
Free Float
30,385,000
Market Cap
$10.94 million
Optionable
Not Optionable
Beta
0.84
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:FREQ) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners